I have answered this several times. The remaining BoD will appoint an interim chairman who will lead the search for an aptly qualified CEO to run the company. NP has not led the company to a single successful trial or approval since 2012. He methods thus far leave a lot to be desired while bleeding the company dry and limiting the company’s financing options to toxic only.
News 
Market Data 
Discover 
